ATH 25.0% 0.3¢ alterity therapeutics limited

WTF !!!, page-28

  1. 1,125 Posts.
    lightbulb Created with Sketch. 107
    Hi Culprum,

    Looking over Dr Stamlers Hx again lastnight, he has held some great positions over his extensive history.

    Reviewing the companies he has been involved in, he sees to have left them all a year or more before being bought out, some for very little, but a huge success with the take over from TEVA pharmaceuticals who bought the rights of Austedo for huntingtons disease, which was bought for 3.6bill, giving share holders $100 per share, as per how much dilution there was in the build up to is unknown.

    But the attached link is worth looking into.

    To me, his approach to enduring no stone is left unturned and his very precise and methodological means of testing ATH434, has been nothing short of very impressive.

    He is showing he wants this to work, and taking all steps required to meet every criteria.

    Enjoy reading his work history.

    https://www.marketscreener.com/insider/DAVID-STAMLER-A0FYX3/
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.